Ranibizumab Biosimilar (Razumab) vs Innovator Ranibizumab (Lucentis) in neovascular age-related macular degeneration (n-AMD)- efficacy and safety (BIRA study).
Ashish SharmaNilesh KumarNikulaa ParachuriFrancesco BandelloBaruch D KuppermannAnat LoewensteinPublished in: Eye (London, England) (2021)